Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report

BACKGROUND: Unfractionated heparin is used worldwide as a standard anticoagulation therapy for extracorporeal membrane oxygenation (ECMO) machines. However, its use brings about significant bleeding and thrombotic complications for critically ill patients. This case report shows that low molecular w...

Descripción completa

Detalles Bibliográficos
Autores principales: Durila, Miroslav, Berousek, Jan, Vlasakova, Vlasta, Vymazal, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088682/
https://www.ncbi.nlm.nih.gov/pubmed/37041623
http://dx.doi.org/10.1186/s13019-023-02226-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088682/
https://www.ncbi.nlm.nih.gov/pubmed/37041623
http://dx.doi.org/10.1186/s13019-023-02226-0

Ejemplares similares